A core laboratory for the generation of quality-controlled g-herpesvirus bacmids: generation of KSHV microRNA mutants by unknown
POSTER PRESENTATION Open Access
A core laboratory for the generation of quality-
controlled g-herpesvirus bacmids: generation of
KSHV microRNA mutants
Brian Krueger, Karlie Plaisance, Rajnikumar Sangani, Curtis Lanier, Vaibhav Jain, Jianhong Hu, Rolf Renne*
From 13th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies
(ICMAOI)
Bethesda, MD, USA. 7-8 November 2011
Kaposi’s sarcoma-associated herpesvirus (KSHV) encodes
12 viral microRNAs that are expressed during latency.
Research into the function of these microRNAs has suf-
fered from the lack of an experimental system that allows
for the systematic removal of individual microRNAs.
Here we have used the E. coli Red recombination system
in conjunction with a new bacmid background, 219BAC,
generated in the Jung Lab to create mutants for every
known KSHV microRNA. The specific microRNA dele-
tions or mutations and the integrity of the viruses has
been strictly quality controlled using PCR, restriction
digestion and sequencing based assays. In addition, stable
viral producer cell lines for wildtype, ΔmiR-K12-1,
ΔmiR-K12-3, and ΔmiR-K12-11 have been created in
iSLK cells generously provided by Don Ganem. Deep
sequencing was employed to sequence verify all of the
current producer cell line mutants and a qPCR assay was
used to verify the expression of the remaining viral
microRNAs. Creation of producer cell lines for all of the
microRNA mutants is ongoing and these viruses will be
made available to the research community for further
study.
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